Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maurice Pasternak1,2, Saira S Mirza1, Nicholas Luciw1,3

  • 1Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|April 16, 2024
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variants.

medRxiv : the preprint server for health sciences·2026
Same author

Predicting progression from subjective cognitive decline to dementia using different neuropsychological criteria: A longitudinal study.

Archives of gerontology and geriatrics·2026
Same author

Peripheral microRNA signature in genetic frontotemporal dementia-findings from the GENFI initiative.

GeroScience·2026
Same author

Coping Strategies Used by Caregivers of Patients With Mild Cognitive Impairment due to Alzheimer's Disease - A Longitudinal Study.

Journal of geriatric psychiatry and neurology·2026
Same author

Composite grey matter fingerprints for genetic frontotemporal dementia.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles
Summary
This summary is machine-generated.

Cerebral perfusion decline tracks genetic frontotemporal dementia (FTD) progression before symptoms appear. Specific regional hypoperfusion patterns emerge in different genetic FTD subtypes, with the left thalamus affected across all groups.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarker Discovery

Context:

  • Genetic frontotemporal dementia (FTD) lacks effective longitudinal biomarkers for its presymptomatic phase.
  • Early detection and tracking of disease progression are crucial for intervention strategies.

Purpose:

  • To investigate the utility of cerebral perfusion as a biomarker in presymptomatic carriers of genetic FTD.
  • To analyze longitudinal changes in cerebral perfusion across different genetic FTD subtypes (C9orf72, GRN, MAPT).

Summary:

  • Longitudinal arterial spin labeling MRI revealed global gray matter perfusion decline in all presymptomatic genetic FTD groups.
  • Distinct regional hypoperfusion patterns were observed, with the left thalamus commonly affected.
  • Individuals who converted to symptomatic FTD showed greater right frontal hypoperfusion compared to asymptomatic carriers.
Keywords:
arterial spin labelingcerebral perfusionfrontotemporal dementiapresymptomatic biomarker

Related Experiment Videos

Impact:

  • Cerebral perfusion serves as a potential early biomarker for identifying and monitoring genetic FTD and its subtypes before symptom onset.
  • Understanding regional perfusion changes can aid in differentiating genetic FTD trajectories.